PetMed Express Sets Key Deadlines for 2026 Shareholder Nominations
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Petmed Express ( (PETS) ) has shared an announcement.
PetMed Express, Inc. has scheduled its 2026 Annual Meeting of Shareholders to be held virtually on August 11, 2026, marking a date change of more than 30 days from the 2025 meeting and triggering new procedural timelines. As a result, prior deadlines tied to the 2025 meeting for shareholder proposals and director nominations are no longer applicable.
The company has set May 31, 2026, as the key cutoff for shareholders to submit Rule 14a-8 proposals, proxy access director nominations, and other proposals or nominations for consideration at the 2026 meeting, with all submissions required to comply with its bylaws and relevant securities rules. These adjustments clarify the governance process for investors, ensuring shareholders have defined timelines and conditions to influence board composition and corporate agenda ahead of the virtual meeting.
The most recent analyst rating on (PETS) stock is a Sell with a $3.00 price target. To see the full list of analyst forecasts on Petmed Express stock, see the PETS Stock Forecast page.
Spark’s Take on PETS Stock
According to Spark, TipRanks’ AI Analyst, PETS is a Neutral.
The score is driven primarily by sharply deteriorating financial performance (losses, contracting revenue, and cash burn). Technicals also remain weak with bearish trend indicators despite oversold readings. Valuation is difficult to support due to negative earnings, and corporate events add incremental risk due to the Nasdaq compliance notice.
To see Spark’s full report on PETS stock, click here.
More about Petmed Express
PetMed Express, Inc. operates in the pet healthcare and pharmacy industry, providing prescription and non-prescription medications and related health products for pets through direct-to-consumer channels. The company focuses on serving pet owners across the U.S. by offering convenient access to veterinary medications and wellness products.
Average Trading Volume: 81,179
Technical Sentiment Signal: Strong Sell
Current Market Cap: $47.72M
Learn more about PETS stock on TipRanks’ Stock Analysis page.
